DNA elements for constitutive androstane receptor- and pregnane X receptor-mediated regulation of bovine CYP3A28 gene

PLoS One. 2019 Mar 25;14(3):e0214338. doi: 10.1371/journal.pone.0214338. eCollection 2019.

Abstract

The regulation of cytochrome P450 3A (CYP3A) enzymes is established in humans, but molecular mechanisms of its basal and xenobiotic-mediated regulation in cattle are still unknown. Here, ~10 kbp of the bovine CYP3A28 gene promoter were cloned and sequenced, and putative transcription factor binding sites were predicted. The CYP3A28 proximal promoter (PP; -284/+71 bp) contained DNA elements conserved among species. Co-transfection of bovine nuclear receptors (NRs) pregnane X and constitutive androstane receptor (bPXR and bCAR) with various CYP3A28 promoter constructs into hepatoma cell lines identified two main regions, the PP and the distal fragment F3 (-6899/-4937 bp), that were responsive to bPXR (both) and bCAR (F3 fragment only). Site-directed mutagenesis and deletion of NR motif ER6, hepatocyte nuclear factor 1 (HNF-1) and HNF-4 binding sites in the PP suggested either the involvement of ER6 element in bPXR-mediated activation or the cooperation between bPXR and liver-enriched transcription factors (LETFs) in PP transactivation. A putative DR5 element within the F3 fragment was involved in bCAR-mediated PP+F3 transactivation. Although DNA enrichment by anti-human NR antibodies was quite low, ChIP investigations in control and RU486-treated BFH12 cells, suggested that retinoid X receptor α (RXRα) bound to ER6 and DR5 motifs and its recruitment was enhanced by RU486 treatment. The DR5 element seemed to be recognized mainly by bCAR, while no clear-cut results were obtained for bPXR. Present results point to species-differences in CYP3A regulation and the complexity of bovine CYP3A28 regulatory elements, but further confirmatory studies are needed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Cattle
  • Cell Line, Tumor
  • Cloning, Molecular / methods*
  • Constitutive Androstane Receptor
  • Cytochrome P-450 CYP3A / chemistry
  • Cytochrome P-450 CYP3A / genetics*
  • Cytochrome P-450 CYP3A / metabolism
  • Gene Expression Regulation
  • Hep G2 Cells
  • Humans
  • Pregnane X Receptor / genetics*
  • Promoter Regions, Genetic
  • Receptors, Cytoplasmic and Nuclear / genetics*
  • Sequence Analysis, DNA
  • Transcription Factors / metabolism
  • Transfection

Substances

  • Constitutive Androstane Receptor
  • Pregnane X Receptor
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors
  • Cytochrome P-450 CYP3A

Grants and funding

This research was supported by the University of Padua [Grants CPDA109434, DOR1673992, DOR1732295 to MG and 60A08-4783/14 to MD] and by Academy of Finland to JK and PH, European Union ERASMUS+ program to PH and the University of Eastern Finland Doctoral Program in Drug Research to VP.